Robocath lands $43m Series C
France and UK-based Robocath, a provider of cardiovascular robotic systems for the treatment of vascular diseases, has secured $43 million in Series C financing.
France and UK-based Robocath, a provider of cardiovascular robotic systems for the treatment of vascular diseases, has secured $43 million in Series C financing.
Copyright PEI Media
Not for publication, email or dissemination